Results 31 to 40 of about 12,784,255 (313)

Overcoming Resistance to Tumor-Targeted and Immune-Targeted Therapies.

open access: yesCancer Discovery, 2021
Resistance to anticancer therapies includes primary resistance, usually related to lack of target dependency or presence of additional targets, and secondary resistance, mostly driven by adaptation of the cancer cell to the selection pressure of ...
M. Aldea   +5 more
semanticscholar   +1 more source

Washed microbiota transplantation improves patients with metabolic syndrome in South China

open access: yesFrontiers in Cellular and Infection Microbiology, 2022
BackgroundMetabolic syndrome (MS) is a growing public health problem worldwide. The clinical impact of fecal microbiota transplantation (FMT) from healthy donors in MS patients is unclear, especially in southern Chinese populations.
Lei Wu   +14 more
doaj   +1 more source

Exploring targeted therapies in oncology [PDF]

open access: yes, 2007
Targeted therapy in oncology is treatment directed at specific biological pathways and processes that play a critical role in carcinogenesis. Increased knowledge regarding the molecular changes underlying tumor progression and metastatis has resulted in ...
Mom, Constantijne Helene
core   +4 more sources

ETV4 transcription factor and MMP13 metalloprotease are interplaying actors of breast tumorigenesis

open access: yesBreast Cancer Research, 2018
Background The ETS transcription factor ETV4 is involved in the main steps of organogenesis and is also a significant mediator of tumorigenesis and metastasis, such as in breast cancer.
Mandy Dumortier   +8 more
doaj   +1 more source

Washed microbiota transplantation improves patients with high blood glucose in South China

open access: yesFrontiers in Endocrinology, 2022
Background and AimsAlthough fecal microbiota transplantation (FMT) from healthy donors has been shown to have hypoglycemic effects in animal models of diabetes, its clinical impact in patients with abnormal blood glucose metabolism is unclear, especially
Lei Wu   +11 more
doaj   +1 more source

Biomarker-Targeted Therapies in Non–Small Cell Lung Cancer: Current Status and Perspectives

open access: yesCells, 2022
Non-small-cell lung cancer (NSCLC) is one of the most common malignancies and the leading causes of cancer-related death worldwide. Despite many therapeutic advances in the past decade, NSCLC remains an incurable disease for the majority of patients ...
Hai-Yan Guo   +8 more
semanticscholar   +1 more source

Defective DNA single-strand break repair is responsible for senescence and neoplastic escape of epithelial cells

open access: yesNature Communications, 2016
It is recognized that cellular senescence is triggered by DNA damage as a protective mechanism against tumorigenesis. Here the authors show that DNA single-strand breaks of oxidative origin can induce a transient senescent state followed by the emergence
Joe Nassour   +13 more
doaj   +1 more source

An Initial Evaluation of Human Plasma cMLC-1: A Potential Protein Biomarker for Trastuzumab-Induced Cardiotoxicity, Breast Cancer Screening and Progression

open access: yesFrontiers in Oncology, 2022
BackgroundTrastuzumab is a targeted therapy for human epidermal growth factor receptor 2 (HER2)-positive breast cancer. However, trastuzumab-induced cardiotoxicity (TIC) has been reported when trastuzumab is administered to patients as a single agent or ...
Ling Yu   +16 more
doaj   +1 more source

New and Emerging Targeted Therapies for Advanced Breast Cancer

open access: yesInternational Journal of Molecular Sciences, 2022
In the United States, breast cancer is among the most frequently diagnosed cancers in women. Breast cancer is classified into four major subtypes: human epidermal growth factor receptor 2 (HER2), Luminal-A, Luminal-B, and Basal-like or triple-negative ...
Kristie Lau, Alexandra M Tan, Yihui Shi
semanticscholar   +1 more source

Melanoma: Molecular genetics, metastasis, targeted therapies, immunotherapies, and therapeutic resistance

open access: yesGenes and Diseases, 2022
Cutaneous melanoma is a common cancer and cases have steadily increased since the mid 70s. For some patients, early diagnosis and surgical removal of melanomas is lifesaving, while other patients typically turn to molecular targeted therapies and ...
William Wagstaff   +14 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy